HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Generalized resistance to thyroid hormones in four patients with nodular goiter].

Abstract
Generalized resistance to thyroid hormone described by S. Refetoff in 1967 is characterized by the presence of goiter, euthyroidism, increased serum value of thyroid hormones and increased or normal serum TSH concentration. We described four patients treated for nodular goiter, where clinical and biochemical studies before and after triiodothyronine treatment (by increasing doses from 20 micrograms to 100 micrograms daily for 10 days) have made it possible to diagnose the Refetoff syndrome. In each case other causes of the increased T4 level were excluded (i.e. tumour of pituitary gland with the TSH increased, TBG high level syndrome, the presence of anti-T3 and anti-T4).
AuthorsK Lacka, I Gradecka-Kubik
JournalPolskie Archiwum Medycyny Wewnetrznej (Pol Arch Med Wewn) Vol. 99 Issue 1 Pg. 38-44 (Jan 1998) Poland
Vernacular TitleZespół uogólnionej oporności na hormony tarczycy u czterech chorych na wole guzowate.
PMID9686502 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Triiodothyronine
  • Thyrotropin
  • Thyroxine
Topics
  • Aged
  • Drug Administration Schedule
  • Drug Resistance
  • Female
  • Goiter, Nodular (blood, therapy)
  • Humans
  • Middle Aged
  • Thyrotropin (blood)
  • Thyroxine (blood)
  • Triiodothyronine (administration & dosage, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: